TRAVERE THERAPEUTICS, INC. Operating Leases, Future Minimum Payments, Next Rolling Twelve Months
TRAVERE THERAPEUTICS, INC. (TVTX) had Operating Leases, Future Minimum Payments, Next Rolling Twelve Months of $2.01 million as of 2017-12-31, per its 10-K filed 2018-07-06.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths · last filed 2018-07-06
- 2017-12-31: Operating Leases, Future Minimum Payments, Next Rolling Twelve Months $2.01M.
- 2017-09-30: Operating Leases, Future Minimum Payments, Next Rolling Twelve Months $2.33M.
- 2017-06-30: Operating Leases, Future Minimum Payments, Next Rolling Twelve Months $2.21M.
- 2017-03-31: Operating Leases, Future Minimum Payments, Next Rolling Twelve Months $1.84M.
| Period end | Operating Leases, Future Minimum Payments, Next Rolling Twelve Months | Operating Leases, Future Minimum Payments, Next Rolling Twelve Months as first filed |
|---|---|---|
| 2017-12-31 | $2.01M 10-K · filed 2018-07-06 | |
| 2017-09-30 | $2.33M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $2.21M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $1.84M 10-Q · filed 2017-05-05 | |
| 2016-09-30 | $1.29M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $1.05M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $1.04M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $2.05M 10-K · filed 2017-03-01 | $1.03M 10-K · filed 2016-02-26 |
| 2015-09-30 | $797.00K 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $1.04M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $1.02M 10-Q · filed 2015-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |